Associate Professor Inês Esteves Domingues Pires da Silva is a Medical Oncologist at the Melanoma Institute Australia
A/Prof Silva is a distinguished Medical Oncologist and Associate Professor specialising in melanoma and immuno-oncology at the Melanoma Institute Australia and The University of Sydney. Her research is dedicated to personalizing and improving immunotherapy outcomes for melanoma patients, with a particular focus on understanding mechanisms of resistance, identifying predictive biomarkers, and defining patterns of treatment response and toxicity.
A prolific researcher, A/Prof Silva has conceived and led numerous international, practice-changing studies that have established effective treatment strategies for patients resistant to standard therapies. Her work has significantly advanced the understanding of how specific metastatic sites, such as the liver, can influence treatment efficacy. She has authored over 90 peer-reviewed publications in prestigious journals including The Lancet Oncology, New England Journal of Medicine, Cancer Cell, and Journal of Clinical Oncology, and has been recognized with multiple prestigious awards from American Society of Clinical Oncology (ASCO), European Society For Medical Oncology (ESMO), and the Melanoma Research Alliance.
A/Prof Silva is a committed mentor and leader in the oncology community, actively serving on scientific committees for ESMO and SMR. She has successfully secured significant competitive funding as Chief Investigator, including grants from the NHMRC, CINSW and the Melanoma Research Alliance, to support her innovative translational research platform.
Information about the award
The Outstanding Mid-Career Researcher Award honours an individual (5 to 10 years post PhD completion) who has demonstrated exceptional research progress and accomplishment.
